G069-0576 Screening compound: 1,3,3-trimethyl-N-(1-methylpiperidin-4-yl)-N-[2-(morpholin-4-yl)ethyl]-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide

G069-0576 Screening compound: 1,3,3-trimethyl-N-(1-methylpiperidin-4-yl)-N-[2-(morpholin-4-yl)ethyl]-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide
G069-0576 Screening compound: 1,3,3-trimethyl-N-(1-methylpiperidin-4-yl)-N-[2-(morpholin-4-yl)ethyl]-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G069-0576
1,3,3-trimethyl-N-(1-methylpiperidin-4-yl)-N-[2-(morpholin-4-yl)ethyl]-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G069-0576

Molecular Formula

C23H36N4O4S (C23 H36 N4 O4 S)

Compound Name

1,3,3-trimethyl-N-(1-methylpiperidin-4-yl)-N-[2-(morpholin-4-yl)ethyl]-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide

IUPAC name

133-trimethyl-N-(1-methylpiperidin-4-yl)-N-[2-(morpholin-4-yl)ethyl]-2-oxo-23-dihydro-1H-indole-5-sulfonamide

SMILES

CC(C)(c(cc(cc1)S(N(CCN2CCOCC2)C2CCN(C)CC2)(=O)=O)c1N1C)C1=O

InChI

InChI=1S/C23H36N4O4S/c1-23(2)20-17-19(5-6-21(20)25(4)22(23)28)32(29,30)27(18-7-9-24(3)10-8-18)12-11-26-13-15-31-16-14-26/h5-6,17-18H,7-16H2,1-4H3

InChI Key

WWWYQPRZQOVWKU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14978433

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

464.63

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.298

Distribution Coefficient, logD

-0.312

Water Solubility, LogSw

-2.47

Polar Surface Area

62.477

Acid Dissociation Constant (pKa)

27.07

Base Dissociation Constant (pKb)

9.00

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

69.60

G069-0576 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with G069-0576 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G069-0576?
Check Price and Availability of G069-0576, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G069-0576 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G069-0576
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G069-0576
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G069-0576 available by request